Cabaletta Bio Statistics
Total Valuation
Cabaletta Bio has a market cap or net worth of $125.84 million. The enterprise value is $22.81 million.
Important Dates
The last earnings date was Thursday, May 15, 2025, before market open.
Earnings Date | May 15, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Cabaletta Bio has 50.74 million shares outstanding. The number of shares has increased by 11.24% in one year.
Current Share Class | 50.74M |
Shares Outstanding | 50.74M |
Shares Change (YoY) | +11.24% |
Shares Change (QoQ) | +1.22% |
Owned by Insiders (%) | 2.98% |
Owned by Institutions (%) | 60.52% |
Float | 43.43M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.04 |
P/TBV Ratio | 1.04 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.96, with a Debt / Equity ratio of 0.24.
Current Ratio | 3.96 |
Quick Ratio | 3.88 |
Debt / Equity | 0.24 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -128.83 |
Financial Efficiency
Return on equity (ROE) is -73.85% and return on invested capital (ROIC) is -44.13%.
Return on Equity (ROE) | -73.85% |
Return on Assets (ROA) | -41.37% |
Return on Invested Capital (ROIC) | -44.13% |
Return on Capital Employed (ROCE) | -102.36% |
Revenue Per Employee | n/a |
Profits Per Employee | -$772,927 |
Employee Count | 164 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.80% in the last 52 weeks. The beta is 2.79, so Cabaletta Bio's price volatility has been higher than the market average.
Beta (5Y) | 2.79 |
52-Week Price Change | -77.80% |
50-Day Moving Average | 1.47 |
200-Day Moving Average | 2.80 |
Relative Strength Index (RSI) | 77.38 |
Average Volume (20 Days) | 2,656,444 |
Short Selling Information
The latest short interest is 5.52 million, so 10.89% of the outstanding shares have been sold short.
Short Interest | 5.52M |
Short Previous Month | 6.10M |
Short % of Shares Out | 10.89% |
Short % of Float | 12.72% |
Short Ratio (days to cover) | 4.64 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -134.25M |
Pretax Income | -89.98M |
Net Income | -126.76M |
EBITDA | -132.44M |
EBIT | -134.25M |
Earnings Per Share (EPS) | -$2.57 |
Full Income Statement Balance Sheet
The company has $131.83 million in cash and $28.79 million in debt, giving a net cash position of $103.04 million or $2.03 per share.
Cash & Cash Equivalents | 131.83M |
Total Debt | 28.79M |
Net Cash | 103.04M |
Net Cash Per Share | $2.03 |
Equity (Book Value) | 121.55M |
Book Value Per Share | 2.40 |
Working Capital | 100.61M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$95.04 million and capital expenditures -$2.18 million, giving a free cash flow of -$97.22 million.
Operating Cash Flow | -95.04M |
Capital Expenditures | -2.18M |
Free Cash Flow | -97.22M |
FCF Per Share | -$1.92 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Cabaletta Bio does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -11.24% |
Shareholder Yield | -11.24% |
Earnings Yield | -100.73% |
FCF Yield | -77.26% |
Analyst Forecast
The average price target for Cabaletta Bio is $20.33, which is 719.76% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $20.33 |
Price Target Difference | 719.76% |
Analyst Consensus | Strong Buy |
Analyst Count | 9 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | -8.98% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |